Abstract:The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A(1) are produced by different Streptomyces strains and are potent inhibitors of DNA gyrase. The biosynthetic gene clusters of all three antibiotics have been cloned and sequenced, and the function of most genes contained therein has been elucidated. In the last years, a number of "unnatural" aminocoumarins could be generated using the genetic information for the biosynthesis of these antibiotics. The investigated enzymes of aminocoumarin biosynthesis have less-than-perfect substrate specificity, facilitating the production of new antibiotics by various methods. Several new aminocoumarins could be produced by targeted genetic manipulation in the natural producers, but also in heterologous host Streptomyces coelicolor after expression of the respective gene cluster. Mutasynthesis experiments, i. e. generation of a cloQ-defective mutant of the clorobiocin producer and feeding of 13 different structural analogs of 3-dimethylallyl-4-hydroxybenzoic acid to this mutant, allowed the isolation of 32 new aminocoumarins. These compounds contained, instead of the genuine 3-dimethylallyl-4-hydroxybenzoyl moiety, the externally added analogs as the acyl components in their structures. Production of new aminocoumarins was also achieved by chemoenzymatic synthesis in vitro. Several biosynthetic enzymes have been heterologously expressed, purified und used for chemoenzymatic synthesis. The structures of the new aminocoumarins were elucidated by NMR and mass spectroscopy. Their inhibitory activity on gyrase in vitro as well as their antibacterial activity was determined. These results give further insight into the structure-activity relationships of aminocoumarins.

Quinomycins with an unusual N -methyl-3-methylsulfinyl-alanine residue from a Streptomyces sp

Nitricquinomycins A-C, Uncommon Naphthopyrrolediones from the Streptomyces Sp. ZS-A45

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Thioquinomycins A-D, Novel Naphthothiophenediones from the Marine-Derived Streptomyces Sp SS17F

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

New analogues of amides and quinolinones produced by Streptomyces sp. YIM S01983

New Compounds from a Hydrothermal Vent Crab-Associated Fungus Aspergillus Versicolor XZ-4.

Salumycin, a New Pyrazolequinone from a Streptomyces Albus J1074 Mutant Strain

Bioactive Polycyclic Quinones from Marine Streptomyces Sp. 182SMLY.

In Vitro Characterization of Echinomycin Biosynthesis: Formation and Hydroxylation of L-tryptophanyl-S-enzyme and Oxidation of (2S,3S) Β-Hydroxytryptophan.

Novel antibacterial alkaloids from the Mariana Trench-derived actinomycete Streptomyces sp. SY2255

Synthesis, cytotoxic and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety.

Anulamycins A–F, Cinnamoyl-Containing Peptides from a Lake Sediment Derived Streptomyces

Lactoquinomycin C and D, Two New Medermycin Derivatives from the Marine-Derived Streptomyces Sp. SS17A

Cytotoxic and antibacterial marfuraquinocins from the deep South China Sea-derived Streptomyces niveus SCSIO 3406

Genome-Directed Discovery of Tetrahydroisoquinolines from Deep-Sea Derived Streptomyces Niveus SCSIO 3406.

Two new spirooxindole alkaloids from rhizosphere strain Streptomyces sp. xzqh-9

Quinazolin-4-one Coupled with Pyrrolidin-2-iminium Alkaloids from Marine-Derived Fungus <em>Penicillium aurantiogriseum</em>

New 3-Hydroxyquinaldic Acid Derivatives from Cultures of the Marine Derived Actinomycete Streptomyces cyaneofuscatus M-157

New Aminocoumarin Antibiotics from Genetically Engineered Streptomyces Strains.

Quinazolin-4-One Coupled With Pyrrolidin-2-Iminium Alkaloids From Marine-Derived Fungus Penicillium Aurantiogriseum